Accessibility Menu
Pharma-Bio Serv logo

Pharma-Bio Serv(OTC) PBSV

Market Cap$9.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-25%
5 Year-37%
1 Year-24%
1 Month-25%
$0.42
-27.16%
-0.16Today
Pharma-Bio Serv last closing stock price
MetricPriceDate
Last closeUSD 0.422026-07-24
Pharma-Bio Serv stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-15.5%USD 0.502026-07-16
1 month-25.22%USD 0.572026-06-17
3 month-15.5%USD 0.502026-04-13
Year to date-19.33%USD 0.522025-12-30
1 year-24.37%USD 0.562025-07-24
3 year-39.78%USD 0.702023-07-25
5 year-37.28%USD 0.672021-07-23
Since inception-24.77%USD 0.562006-12-04

Pharma-Bio Serv Financials at a Glance

Market Cap

$9.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$9.11M

Net Income (TTM)

$61.49K

EPS (TTM)

$0.00

P/E Ratio

156.48

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$0.42

Volume

2,510

Open

$0.42

Previous Close

$0.42

Daily Range

$0.42 - $0.42

52-Week Range

$0.40 - $1.19

Estimated Earnings Date

Sep 21, 2026

PBSV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharma-Bio Serv

Pharma-Bio Serv helps drug and medical companies meet safety and quality rules. Its experts guide clients through complex regulations and technical changes. This work supports safer medicines and products for everyday consumers.

Consulting, Compliance, and More: What’s on Offer?

  • Time and material contracts: Account for approximately 99% of revenue.
  • Validation services: Checks that equipment and processes work as required for safe production.
  • Technology transfer support: Assists companies moving products or processes between locations or teams.
  • Engineering consulting: Offers technical advice for building or improving manufacturing systems.
  • Project management: Coordinates complex projects to keep them on track and within budget.
  • Process support: Provides ongoing help to improve or troubleshoot production lines.

Growth Moves: Pharma-Bio’s Expansion Playbook

  • Entered the U.S. and European markets after building a base in Puerto Rico.
  • Expanded into Brazil, focusing on compliance consulting for local industries (timeline: recent years).
  • Launched an AI-based lead generation platform in August 2024 with a minority stake in an AI company.
  • Increased business development efforts through trade shows and industry events (ongoing).

What Makes Pharma-Bio Serv Stand Out?

The company operates across Puerto Rico, the U.S. Europe, and Brazil, serving global clients. Its team includes former regulators and industry experts, supporting strong client relationships. Pharma-Bio Serv relies on project-based contracts, adapting quickly to changing client needs.

Five Things You Need to Know

  • Revenue was $9.5 million in FY 2024, down 44.0% from FY 2023.
  • Puerto Rico made up 59.8% of 2024 revenue; U.S. 33.3%; Europe 6.0%.
  • Gross profit margin was 26.5% in FY 2024, down from 29.8% in FY 2023.
  • Net loss was $0.78 million in FY 2024, compared to $1.31 million net income in FY 2023.
  • Three customers accounted for 38.1% of total revenue in FY 2024.

Bottom Line

Pharma-Bio Serv has shifted from growth to managing revenue declines and operational challenges. Its focus remains on compliance consulting for regulated industries across several regions.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

75

CEO

Victor Sanchez, MBA

Website

www.pharmabioserv.com

Headquarters

Dorado, PR 00646, PR

PBSV Financials

Key Financial Metrics (TTM)

Gross Margin

32.35%

Operating Margin

-4.36%

Net Income Margin

0.67%

Return on Equity

0.00%

Return on Capital

-5.34%

Return on Assets

0.00%

Earnings Yield

0.64%

Dividend Yield

0.00%

Payout Ratio

55.86%

Stock Overview

Market Cap

$9.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

22.90M

Volume

2.51K

Avg. Volume

484.508

Financials (TTM)

Gross Profit

$2.95M

Operating Income

-$397.01K

EBITDA

-$116.90K

Operating Cash Flow

-$365.18M

Capital Expenditure

-$7.12K

Free Cash Flow

-$365.19M

Cash & ST Invst.

$8.47M

Total Debt

$0.00

Pharma-Bio Serv Performance Analysis

Pharma-Bio Serv annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31USD 19,398,727-3.6%
20232023-10-31USD 16,976,856-12.5%
20242024-10-31USD 9,509,279-44.0%
20252025-10-31USD 9,001,096-5.3%
Pharma-Bio Serv sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-18.8%
Q42025-10-319.5%
Q12026-01-316.8%
Q22026-04-3017.8%
Pharma-Bio Serv annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31USD 0.04N/A
20232023-10-31USD 0.0630.4%
20242024-10-31USD -0.03N/A
20252025-10-31USD -0.00-87.0%
Pharma-Bio Serv sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-311.9%
Q42025-10-31-4057.3%
Q12026-01-31100.4%
Q22026-04-30628.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.70M

+11.8%

Gross Profit

$902.04K

+10.2%

Gross Margin

33.37%

N/A

Market Cap

$9.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$175.93K

N/A

Employees

55

N/A

Net Income

$232.99K

+144.3%

EBITDA

$158.32K

+522.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$8.47M

-18.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$2.72M

+1.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

-$365.31M

-119342.0%

Operating Cash Flow

-$365.31M

-121028.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUMIFNuminus Wellness Inc.
$0.04+13.64%
SPLTFSpotLite360 IOT Solutions, Inc.
$0.08+0.00%
VYNDVynleads, Inc.
$0.41+0.00%
UDOCFUnidoc Health Corp.
$0.06-3.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About PBSV

What is the current price of Pharma-Bio Serv?

Pharma-Bio Serv is trading at $0.42 per share.

What is the 52-week range for Pharma-Bio Serv?

Over the past 52 weeks, Pharma-Bio Serv has traded between $0.40 and $1.19.

How much debt does Pharma-Bio Serv have?

As of the most recent reporting period, Pharma-Bio Serv reported total debt of $0.00.

How much cash does Pharma-Bio Serv have on hand?

Pharma-Bio Serv reported $1.79M in cash and cash equivalents in its most recent financial results.

What is Pharma-Bio Serv’s dividend yield?

Pharma-Bio Serv does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services